Targeting the DNA damage response for cancer therapy by inhibiting the kinase Wee1

AB Bukhari, GK Chan, AM Gamper - Frontiers in Oncology, 2022 - frontiersin.org
Cancer cells typically heavily rely on the G2/M checkpoint to survive endogenous and
exogenous DNA damage, such as genotoxic stress due to genome instability or radiation …

DNA damage response inhibitors: An avenue for TNBC treatment

J **, Z Tao, J Cao, T Li, X Hu - … et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
The DNA damage response (DDR) is critical for the maintenance of genomic stability by
sensing DNA damage, regulating cell cycle and initiating DNA repair. Drugs targeting DDR …

FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress

A Brunner, Q Li, S Fisicaro, A Kourtesakis, J Viiliäinen… - Molecular Cell, 2023 - cell.com
Fanconi anemia (FA) signaling, a key genomic maintenance pathway, is activated in
response to replication stress. Here, we report that phosphorylation of the pivotal pathway …

DNA damage response in breast cancer and its significant role in guiding novel precise therapies

J Li, Z Jia, L Dong, H Cao, Y Huang, H Xu, Z **e… - Biomarker …, 2024 - Springer
DNA damage response (DDR) deficiency has been one of the emerging targets in treating
breast cancer in recent years. On the one hand, DDR coordinates cell cycle and signal …

Identification of a Notch transcriptomic signature for breast cancer

EB Braune, F Geist, X Tang, K Kalari, J Boughey… - Breast Cancer …, 2024 - Springer
Abstract Background Dysregulated Notch signalling contributes to breast cancer
development and progression, but validated tools to measure the level of Notch signalling in …

Targeting WEE1 inhibits growth of breast cancer cells that are resistant to endocrine therapy and CDK4/6 inhibitors

Y Fallah, DM Demas, L **, W He… - Frontiers in …, 2021 - frontiersin.org
Despite the success of antiestrogens in extending overall survival of patients with estrogen
receptor positive (ER+) breast tumors, resistance to these therapies is prevalent. ER+ tumors …

An update of predictive biomarkers related to WEE1 inhibition in cancer therapy

Z Wang, W Li, F Li, R **ao - Journal of Cancer Research and Clinical …, 2024 - Springer
Purpose WEE1 is a crucial kinase involved in the regulation of G2/M checkpoint within the
cell cycle. This article aims to comprehensively review the existing knowledge on the …

Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors

S Sokhi, CW Lewis, AB Bukhari, J Hadfield… - Frontiers in Cell and …, 2023 - frontiersin.org
Cell cycle checkpoint kinases serve as important therapeutic targets for various cancers.
When they are inhibited by small molecules, checkpoint abrogation can induce cell death or …

A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)

E Maldonado, WK Rathmell, GI Shapiro… - Cancer research …, 2024 - aacrjournals.org
We sought to evaluate the efficacy of WEE1 inhibitor adavosertib in patients with solid tumor
malignancies (cohort A) and clear cell renal cell carcinoma (ccRCC; cohort B) …

Autophagy and PTEN in DNA damage-induced senescence

A Sharma, A Almasan - Advances in cancer research, 2021 - Elsevier
The use of DNA-damaging agents such as radiotherapy and chemotherapy has been a
mainstay treatment protocol for many cancers, including lung and prostate. Recently, FDA …